Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. | Chief Financial Officer | $257K | -$1.09M | -81% | Aug 21, 2025 |
DRMA, DRMAW | Dermata Therapeutics, Inc. | Director | Jan 13, 2025 | |||
NKGN, NKGNW | NKGen Biotech, Inc. | Director | Dec 6, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|